The Human CD86 Monoclonal Antibody (PE Conjugated, BU63) is a key research tool for scientists studying the immune system and cell signaling pathways. This antibody, available from Assay Genie, specifically targets CD86, a crucial co-stimulatory molecule involved in T cell activation and immune responses.The monoclonal antibody is optimized for fluorescence-based assays, making it ideal for flow cytometry and immunofluorescence applications. Its PE conjugation allows for easy and efficient detection of CD86 expression on cell surfaces, providing valuable insights into immune cell activation and regulation.
Researchers can rely on the high quality and specificity of this antibody, as it is rigorously validated for use in human samples. Whether investigating autoimmune diseases, infectious pathologies, or immunotherapy strategies, the Human CD86 Monoclonal Antibody (PE Conjugated, BU63) from Assay Genie serves as a reliable tool for advancing understanding in immunology research.
Each lot of this antibody is quality control tested by flow cytometric analysis. The amount of the reagent is suggested to be used 5 µL of antibody per test (million cells in 100 µL staining volume or per 100 µL of whole blood). Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use.
Spectrum:
Swissprot:
P42081
Gene ID:
942
Storage Buffer:
Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer and 1% protein protectant.
Stability & Storage:
Keep as concentrated solution. Store at 2~8°C and protected from prolonged exposure to light. Do not freeze. Centrifuge before opening to ensure complete recovery of vial contents. This product is guaranteed up to one year from purchase.
Background:
CD86 is an 80 kD immunoglobulin superfamily member also known as B7-2, B70, and Ly-58. CD86 is expressed on activated B and T cells, monocytes/macrophages, dendritic cells, and astrocytes. CD86, along with CD80, is the ligand of CD28 and CD152 (CTLA-4). CD86 is expressed earlier in the immune response than CD80. CD86 has also been shown to be involved in immunoglobulin class-switching and triggering of NK cell-mediated cytotoxicity. CD86 binds to CD28 to transduce costimulatory signals for T cell activation, proliferation, and cytokine production. CD86 can bind to CD152 as well, also known as CTLA-4, to deliver an inhibitory signal to T cells.